• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19: more than a cytokine storm.

作者信息

Riva Giovanni, Nasillo Vincenzo, Tagliafico Enrico, Trenti Tommaso, Comoli Patrizia, Luppi Mario

机构信息

Department of Laboratory Medicine and Pathology, AUSL/AOU Policlinico, Modena, Italy.

Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia; Hematology Unit, AOU Policlinico, Via Del Pozzo 71, 41124, Modena, Italy.

出版信息

Crit Care. 2020 Sep 4;24(1):549. doi: 10.1186/s13054-020-03267-w.

DOI:10.1186/s13054-020-03267-w
PMID:32887652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7472946/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2df/7487959/bebf34fd3d55/13054_2020_3267_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2df/7487959/bebf34fd3d55/13054_2020_3267_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2df/7487959/bebf34fd3d55/13054_2020_3267_Fig1_HTML.jpg

相似文献

1
COVID-19: more than a cytokine storm.新冠病毒肺炎：不止是一场细胞因子风暴
Crit Care. 2020 Sep 4;24(1):549. doi: 10.1186/s13054-020-03267-w.
2
Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure-a cautionary case series.英夫利昔单抗治疗重症新型冠状病毒肺炎所致细胞因子风暴综合征伴器官衰竭——警示性病例系列
Crit Care. 2020 Jul 17;24(1):444. doi: 10.1186/s13054-020-03158-0.
3
[Anti-cytokine therapy in novel coronavirus disease (COVID-19) – the first administration of tocilizumab in Hungary at a department of infectology].新型冠状病毒肺炎（COVID-19）的抗细胞因子治疗——匈牙利感染病科首次使用托珠单抗治疗
Orv Hetil. 2020 Jun;161(26):1070-1077. doi: 10.1556/650.2020.31899.
4
Cellular immune responses to covid-19.对新冠病毒的细胞免疫反应。
BMJ. 2020 Jul 31;370:m3018. doi: 10.1136/bmj.m3018.
5
Is a "Cytokine Storm" Relevant to COVID-19?“细胞因子风暴”与新冠病毒病有关吗？
JAMA Intern Med. 2020 Sep 1;180(9):1152-1154. doi: 10.1001/jamainternmed.2020.3313.
6
[Low dose lung radiotherapy for COVID-19-related cytokine storm syndrome: Why not?].[低剂量肺部放疗治疗 COVID-19 相关细胞因子风暴综合征：为何不呢？]
Cancer Radiother. 2020 Jun;24(3):179-181. doi: 10.1016/j.canrad.2020.04.003. Epub 2020 May 1.
7
COVID-19 and hypertensive disease in Brazil: possibility of a perfect storm.巴西的新冠疫情与高血压疾病：一场完美风暴的可能性。
Rev Bras Epidemiol. 2020;23:e200062. doi: 10.1590/1980-549720200062. Epub 2020 Jul 17.
8
Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists.使用α-1肾上腺素能受体拮抗剂预防新冠病毒疾病中的细胞因子风暴综合征
J Clin Invest. 2020 Jul 1;130(7):3345-3347. doi: 10.1172/JCI139642.
9
[Not Available].[无可用内容]
Rev Med Suisse. 2020 May 13;16(693):1012-1013.
10
Nursing Perspectives on the Impacts of COVID-19.护理视角下的新冠疫情影响
J Nurs Res. 2020 Jun;28(3):e85. doi: 10.1097/NRJ.0000000000000389.

引用本文的文献

1
COVID-19 Pneumonia and Cytokine Storm Syndrome.新型冠状病毒肺炎及细胞因子风暴综合征
Adv Exp Med Biol. 2024;1448:307-319. doi: 10.1007/978-3-031-59815-9_22.
2
Aripiprazole as protector against COVID-19 mortality.阿立哌唑作为 COVID-19 死亡率的保护剂。
Sci Rep. 2024 May 29;14(1):12362. doi: 10.1038/s41598-024-60297-y.
3
Evaluation of the Efficacy and Safety of Intravenous Immunoglobulin (IVIG) in Moderate-to-Severe Hospitalized COVID-19 Patients: A Randomized, Open-Label Parallel-Group Study.静脉注射免疫球蛋白（IVIG）治疗中重度住院COVID-19患者的疗效和安全性评估：一项随机、开放标签平行组研究。

本文引用的文献

1
The unique characteristics of COVID-19 coagulopathy.COVID-19 凝血功能障碍的独特特征。
Crit Care. 2020 Jun 18;24(1):360. doi: 10.1186/s13054-020-03077-0.
2
The immune system of children: the key to understanding SARS-CoV-2 susceptibility?儿童的免疫系统：理解对新冠病毒易感性的关键？
Lancet Child Adolesc Health. 2020 Jun;4(6):414-416. doi: 10.1016/S2352-4642(20)30135-8. Epub 2020 May 6.
3
Immunotherapies for COVID-19: lessons learned from sepsis.新冠病毒病的免疫疗法：脓毒症的经验教训
Can J Infect Dis Med Microbiol. 2024 May 21;2024:7209380. doi: 10.1155/2024/7209380. eCollection 2024.
4
Small Molecules for the Treatment of Long-COVID-Related Vascular Damage and Abnormal Blood Clotting: A Patent-Based Appraisal.小分子药物治疗长新冠相关血管损伤和异常血栓形成：基于专利的评估。
Viruses. 2024 Mar 14;16(3):450. doi: 10.3390/v16030450.
5
Monocyte Distribution Width Predicts Sepsis, Respiratory Failure, and Death in COVID-19.单核细胞分布宽度可预测 COVID-19 患者的脓毒症、呼吸衰竭及死亡情况。
Cureus. 2023 Dec 14;15(12):e50525. doi: 10.7759/cureus.50525. eCollection 2023 Dec.
6
Innate IRE1α-XBP1 activation by viral single-stranded RNA and its influence on lung cytokine production during SARS-CoV-2 pneumonia.病毒单链 RNA 对固有 IRE1α-XBP1 的激活及其对 SARS-CoV-2 肺炎肺细胞因子产生的影响。
Genes Immun. 2024 Feb;25(1):43-54. doi: 10.1038/s41435-023-00243-6. Epub 2023 Dec 25.
7
A Comparison between SARS-CoV-2 and Gram-Negative Bacteria-Induced Hyperinflammation and Sepsis.SARS-CoV-2 与革兰氏阴性菌诱导的过度炎症和脓毒症的比较。
Int J Mol Sci. 2023 Oct 14;24(20):15169. doi: 10.3390/ijms242015169.
8
Cytokine storm and severe hepatitis in pregnancy due to herpes simplex virus 2.因单纯疱疹病毒 2 引起的妊娠时细胞因子风暴和重症肝炎。
Infection. 2024 Feb;52(1):259-263. doi: 10.1007/s15010-023-02092-x. Epub 2023 Sep 27.
9
Epidemiology of infection, transmission and COVID-19 outcomes among mental health users and workers in a comprehensive network of long-term mental health facilities: Retrospective observational population-base study.长期精神卫生设施综合网络中精神卫生使用者和工作人员的感染、传播及 COVID-19 结局的流行病学：回顾性观察性基于人群的研究。
Schizophr Res. 2023 Apr;254:1-7. doi: 10.1016/j.schres.2023.01.020. Epub 2023 Jan 20.
10
SARS-CoV-2 Altered Hemorheological and Hematological Parameters during One-Month Observation Period in Critically Ill COVID-19 Patients.在重症 COVID-19 患者一个月的观察期间，SARS-CoV-2 改变了血液流变学和血液学参数。
Int J Mol Sci. 2022 Dec 5;23(23):15332. doi: 10.3390/ijms232315332.
Lancet Respir Med. 2020 Oct;8(10):946-949. doi: 10.1016/S2213-2600(20)30217-4. Epub 2020 Apr 28.
4
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19).新型冠状病毒病（COVID-19）患者 T 细胞减少和功能耗竭。
Front Immunol. 2020 May 1;11:827. doi: 10.3389/fimmu.2020.00827. eCollection 2020.
5
COVID-19: room for treating T cell exhaustion?新型冠状病毒肺炎：治疗T细胞耗竭的空间？
Crit Care. 2020 May 15;24(1):229. doi: 10.1186/s13054-020-02960-0.
6
Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date.恢复期供体的新冠病毒特异性细胞毒性T淋巴细胞输注作为重症COVID-19患者的一种可能治疗选择，迄今为止尚未得到足够关注。
Br J Haematol. 2020 Jun;189(6):1062-1063. doi: 10.1111/bjh.16780. Epub 2020 May 19.
7
SARS-CoV-2 and viral sepsis: observations and hypotheses.SARS-CoV-2 与病毒败血症：观察与假说。
Lancet. 2020 May 9;395(10235):1517-1520. doi: 10.1016/S0140-6736(20)30920-X. Epub 2020 Apr 17.
8
Cytokine release syndrome in severe COVID-19.重症新型冠状病毒肺炎中的细胞因子释放综合征
Science. 2020 May 1;368(6490):473-474. doi: 10.1126/science.abb8925. Epub 2020 Apr 17.
9
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease.细胞因子（包括白细胞介素 6）在 COVID-19 诱导性肺炎和巨噬细胞活化综合征样疾病中的作用。
Autoimmun Rev. 2020 Jun;19(6):102537. doi: 10.1016/j.autrev.2020.102537. Epub 2020 Apr 3.
10
Clinical and immunological features of severe and moderate coronavirus disease 2019.新型冠状病毒病 2019 重症和中度患者的临床和免疫学特征。
J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.